Literature DB >> 25277678

Ebola: a call for blood transfusion strategy in sub-Saharan Africa.

Thierry Burnouf1, Jean Emmanuel2, Dora Mbanya3, Magdy El-Ekiaby4, William Murphy5, Stephen Field6, Jean-Pierre Allain7.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25277678     DOI： 10.1016/S0140-6736(14)61693-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  17 in total

1.  Ebola control: effect of asymptomatic infection and acquired immunity.

Authors:  Steve E Bellan; Juliet R C Pulliam; Jonathan Dushoff; Lauren Ancel Meyers
Journal:  Lancet       Date:  2014-10-15       Impact factor: 79.321

2.  Evaluating large-scale blood transfusion therapy for the current Ebola epidemic in Liberia.

Authors:  Alexander Gutfraind; Lauren Ancel Meyers
Journal:  J Infect Dis       Date:  2015-01-29       Impact factor: 5.226

3.  Minipool caprylic acid fractionation of plasma using disposable equipment: a practical method to enhance immunoglobulin supply in developing countries.

Authors:  Magdy El-Ekiaby; Mariángela Vargas; Makram Sayed; George Gorgy; Hadi Goubran; Mirjana Radosevic; Thierry Burnouf
Journal:  PLoS Negl Trop Dis       Date:  2015-02-26

4.  TnBP⁄Triton X-45 treatment of plasma for transfusion efficiently inactivates hepatitis C virus.

Authors:  Ming-Li Chou; Thierry Burnouf; Shun-Pang Chang; Ting-Chun Hung; Chun-Ching Lin; Christopher D Richardson; Liang-Tzung Lin
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

5.  Treatment of Ebola virus infection with antibodies from reconvalescent donors.

Authors:  Thomas R Kreil
Journal:  Emerg Infect Dis       Date:  2015-03       Impact factor: 6.883

Review 6.  Whole blood pathogen reduction technology and blood safety in sub-Saharan Africa: A systematic review with regional discussion.

Authors:  Asa'ah Nkohkwo; Gabriel Agbor; Emmanuel Asongalem; Claude Tagny; Tazoacha Asonganyi
Journal:  Afr J Lab Med       Date:  2016-06-09

7.  Organizing the Donation of Convalescent Plasma for a Therapeutic Clinical Trial on Ebola Virus Disease: The Experience in Guinea.

Authors:  Alexandre Delamou; Nyankoye Yves Haba; Almudena Mari-Saez; Pierre Gallian; Maya Ronse; Jan Jacobs; Bienvenu Salim Camara; Kadio Jean-Jacques Olivier Kadio; Achille Guemou; Jean Pe Kolie; Maaike De Crop; Patricia Chavarin; Chantal Jacquot; Catherine Lazaygues; Anja De Weggheleire; Lutgarde Lynen; Johan van Griensven
Journal:  Am J Trop Med Hyg       Date:  2016-07-18       Impact factor: 2.345

8.  Use of COVID-19 convalescent plasma in low- and middle-income countries: a call for ethical principles and the assurance of quality and safety.

Authors:  Jay Epstein; W Martin Smid; Silvano Wendel; Daniel Somuah; Thierry Burnouf
Journal:  Vox Sang       Date:  2020-06-24       Impact factor: 2.996

9.  The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the Field.

Authors:  Johan van Griensven; Anja De Weiggheleire; Alexandre Delamou; Peter G Smith; Tansy Edwards; Philippe Vandekerckhove; Elhadj Ibrahima Bah; Robert Colebunders; Isola Herve; Catherine Lazaygues; Nyankoye Haba; Lutgarde Lynen
Journal:  Clin Infect Dis       Date:  2015-08-10       Impact factor: 9.079

10.  Guidance for the procurement of COVID-19 convalescent plasma: differences between high- and low-middle-income countries.

Authors:  Evan M Bloch; Ruchika Goel; Silvano Wendel; Thierry Burnouf; Arwa Z Al-Riyami; Ai Leen Ang; Vincenzo DeAngelis; Larry J Dumont; Kevin Land; Cheuk-Kwong Lee; Adaeze Oreh; Gopal Patidar; Steven L Spitalnik; Marion Vermeulen; Salwa Hindawi; Karin Van den Berg; Pierre Tiberghien; Hans Vrielink; Pampee Young; Dana Devine; Cynthia So-Osman
Journal:  Vox Sang       Date:  2020-07-20       Impact factor: 2.996
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.